Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
about
International guidelines for contrast-enhanced ultrasonography: ultrasound imaging in the new millenniumNoninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining IssuesRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIA lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesionsLiver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinomaDevelopment of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal ModelTriple Arterial Phase MR Imaging with Gadoxetic Acid Using a Combination of Contrast Enhanced Time Robust Angiography, Keyhole, and Viewsharing Techniques and Two-Dimensional Parallel Imaging in Comparison with Conventional Single Arterial Phase.Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.Unenhanced areas revealed by contrast-enhanced abdominal ultrasonography with Sonazoid™ potentially correspond to colorectal cancer.Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.Significant biomarkers for the management of hepatocellular carcinoma.Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma.Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
P2860
Q26766603-4AACF066-9D5E-4C2E-BEDA-3A27C2B391D8Q26770020-AC5A49D4-0DA0-4A15-B039-32ED7F04801AQ28075361-EAD2B442-5BB1-4479-9B05-DB56F1B087F1Q30359302-8C3A9B82-28BC-4491-9BF8-850A59C13D70Q31108230-19858477-F06C-4A62-8420-BF6B0E61228CQ31118557-4DCDCA42-0FD1-4730-9A25-7AFBA95C5DD1Q33561375-DE661FD9-9720-4BC5-ACB2-9FAF687CC86EQ33566921-48F1CC90-6B9F-4761-9B66-B5346C062CF5Q35740912-D77D7335-AE3D-427D-B72E-3B3BBDC9CAF1Q35926191-BFB45AFD-F116-498B-A2A8-A55385C2B9B3Q37073543-DAA77CBB-CDF2-4B48-A2C1-5F688EEAD8BFQ37096406-C5FAF1F1-344C-4D8B-A04B-6B70756BDE1CQ37582281-3C1A9699-6A5E-443A-8997-A6E27979D8A4Q38399641-DA000BDC-E33E-46DB-86D6-204CA7F04720Q38412315-33C6403E-8491-4BB5-8C76-8734DF588C26Q38676421-E95C2E71-C2B2-4E5E-83E3-3F452FAD8BA7Q38976824-0ACA19C5-075F-4DFF-AA63-913597F0A5E1Q41962614-D8A34892-FB3F-4806-BFD5-5622397CDBC2Q43171014-FD7FA9C6-D69A-4A44-B30A-D1F3759A9131Q47145890-3BC5F75B-B8E5-4972-ADBD-BC9B81D87A97Q47225007-6D06383E-A68F-4639-BEA7-3A4C8077B460Q47328128-F273B0B8-2362-4925-A200-CAC062DF8388Q48234623-89465B3E-1A50-44DF-BE63-1F56F88D42D2Q48622310-4FC16614-843A-492F-97F7-46FDAEA94505Q53089913-25CE5960-DB91-4508-8BB2-1D2539411275Q55130824-E44AF618-49B2-4AF4-8FDB-71826D58177CQ55227929-82F30EC1-01A6-4AF6-B64D-B816DE94C599Q55339831-4F399C55-07E5-4879-87FC-84179957850F
P2860
Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Surveillance and diagnostic al ...... y Group of Japan: 2014 update.
@en
type
label
Surveillance and diagnostic al ...... y Group of Japan: 2014 update.
@en
prefLabel
Surveillance and diagnostic al ...... y Group of Japan: 2014 update.
@en
P2093
P356
P1433
P1476
Surveillance and diagnostic al ...... y Group of Japan: 2014 update.
@en
P2093
Hiroko Iijima
Liver Cancer Study Group of Japan
Masumi Kadoya
Namiki Izumi
Osamu Matsui
Yasuharu Imai
P356
10.1159/000368141
P478
87 Suppl 1
P577
2014-11-22T00:00:00Z